Progress on small-molecule proteolysis-targeting chimeras

Future Med Chem. 2019 Oct;11(20):2715-2734. doi: 10.4155/fmc-2019-0161. Epub 2019 Oct 1.

Abstract

Proteolysis-targeting chimeras (PROTACs) have received much attention for their promising therapeutic intervention in recent years. These molecules, with the mechanism of simultaneous recruitment of target protein and an E3 ligase, can trigger the cellular ubiquitin-proteasome system to degrade the target proteins. This article systematically introduces the mechanism of small-molecule PROTACs, and summarized the research progress of small-molecule PROTACs. The prospect for further application and the problems to be solved are also discussed.

Keywords: E3 ligases; PROTACs; degrader; induced protein degradation; small molecules; ubiquitinproteasome system.

Publication types

  • Research Support, Non-U.S. Gov't
  • Systematic Review

MeSH terms

  • Cell Line, Tumor
  • Humans
  • Proteasome Endopeptidase Complex / metabolism
  • Proteolysis
  • Recombinant Fusion Proteins / chemistry*
  • Ubiquitin / metabolism

Substances

  • Recombinant Fusion Proteins
  • Ubiquitin
  • Proteasome Endopeptidase Complex